Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study

Pascale Fabbro-Peray,Sonia Zouaoui,Amélie Darlix,Michel Fabbro,Johan Pallud,Valérie Rigau,H. Mathieu-Daude,Faiza Bessaoud,Fabienne Bauchet,Adeline Riondel,Elodie Sorbets,M. Charissoux,Aymeric Amelot,Emmanuel Mandonnet,Dominique Figarella-Branger,Hugues Duffau,Brigitte Trétarre,Luc Taillandier,Luc Bauchet

Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study

2019

Pascale Fabbro-Peray
Sonia Zouaoui
Amélie Darlix
Michel Fabbro
Johan Pallud
Valérie Rigau
H. Mathieu-Daude
Faiza Bessaoud
Fabienne Bauchet
Adeline Riondel
Elodie Sorbets
M. Charissoux
Aymeric Amelot
Emmanuel Mandonnet
Dominique Figarella-Branger
Hugues Duffau
Brigitte Trétarre
Luc Taillandier
Luc Bauchet

Background Glioblastoma is the most frequent primary malignant brain tumor. In daily practice and at whole country level, oncological care management for glioblastoma patients is not completely known.

Keywords:

Cancer research
Temozolomide
Glioblastoma
Neurosurgery
Malignant brain tumor
Oncology
Medicine
Radiation therapy
Population
Internal medicine
population based study
newly diagnosed
Neurology
patterns of care

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations